| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1981PNAS...78.7219G |
| P356 | DOI | 10.1073/PNAS.78.11.7219 |
| P932 | PMC publication ID | 349228 |
| P698 | PubMed publication ID | 6118870 |
| P5875 | ResearchGate publication ID | 17067182 |
| P2093 | author name string | L Hood | |
| A Goldstein | |||
| L I Lowney | |||
| W Fischli | |||
| M Hunkapiller | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Dynorphin-(1-13), an extraordinarily potent opioid peptide | Q24561638 | ||
| Immunoreactive dynorphin in pituitary and brain | Q24609641 | ||
| Human chorionic gonadotropin. Linear amino acid sequence of the beta subunit | Q28245662 | ||
| Dynorphin immunocytochemical localization in brain and peripheral nervous system: preliminary studies | Q35428154 | ||
| Morphine-tolerant longitudinal muscle strip from guinea-pig ileum | Q35600240 | ||
| Specific receptor for the opioid peptide dynorphin: structure--activity relationships | Q36376431 | ||
| In Vitro Models in the Study of Structure-Activity Relationships of Narcotic Analgesics | Q38120971 | ||
| A pituitary endorphin with novel properties | Q40254821 | ||
| The amino-acid sequence of leghemoglobin component a from Phaseolus vulgaris (kidney bean) | Q45110669 | ||
| A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties | Q48455254 | ||
| Snake venom toxins. The purification of toxins VII1 and VII2, two cytotoxin homologues from banded Egyptian cobra (Naja haje annulifera) venom, and the complete amino acid sequence of toxin VII1 | Q69717956 | ||
| New protein sequenator with increased sensitivity | Q71130683 | ||
| Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus | Q72896061 | ||
| The amino acid sequence of cytochrome c(3) from Desulfovibrio desulfuricans (strain el agheila Z, NCIB 8380) | Q77917992 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dynorphin | Q324076 |
| P304 | page(s) | 7219-7223 | |
| P577 | publication date | 1981-11-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide | |
| P478 | volume | 78 |
| Q33652922 | "DAKLI": a multipurpose ligand with high affinity and selectivity for dynorphin (kappa opioid) binding sites |
| Q30481450 | 30 years of dynorphins--new insights on their functions in neuropsychiatric diseases |
| Q24670315 | 75 years of opioid research: the exciting but vain quest for the Holy Grail |
| Q24562762 | A brief history of opiates, opioid peptides, and opioid receptors |
| Q36297189 | A dynorphin-like opioid in the central nervous system of an amphibian |
| Q59084083 | A dynorphinergic pathway of Leu-enkephalin production in rat substantia nigra |
| Q44345342 | Alanine scan of the opioid peptide dynorphin B amide. |
| Q44115274 | An inhibitor of endopeptidase-24.15 blocks the degradation of intraventricularly administered dynorphins |
| Q44344563 | Are opioid peptides co-localized with vasopressin or oxytocin in the neural lobe of the rat? |
| Q37744084 | Chimeric opioid peptides: tools for identifying opioid receptor types |
| Q41107282 | Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression |
| Q30744891 | Cloning and characterization of Xen-dorphin prohormone from Xenopus laevis: a new opioid-like prohormone distinct from proenkephalin and prodynorphin |
| Q34707265 | Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor |
| Q48836992 | Co-existence of unrelated peptides in oxytocin and vasopressin terminals of rat neurohypophyses: Immunoreactive methionine5-enkephalin-, leucine5- enkephalin- and cholecystokinin-like substances |
| Q48860073 | Comparison of the Distribution of Dynorphin Systems and Enkephalin Systems in Brain |
| Q73966943 | Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides |
| Q46640668 | Conformational analysis of dynorphin A (1-13) using hydrogen-deuterium exchange and tandem mass spectrometry |
| Q38818332 | Cyclic Opioid Peptides |
| Q52170045 | Des-tyrosine(1) dynorphin A-(2-13) improves carbon monoxide-induced impairment of learning and memory in mice. |
| Q35150480 | Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesis |
| Q37576387 | Differential processing of prodynorphin and proenkephalin in specific regions of the rat brain. |
| Q48820669 | Differential regulation of oxytocin- and vasopressin-secreting nerve terminals |
| Q40649124 | Dipeptidyl peptidase IV (DPPIV) enzyme activity on immature T-cell line R1.1 is down-regulated by dynorphin-A(1–17) as a non-substrate inhibitor |
| Q42449271 | Double immunostaining reveals distinctions among opioid peptidergic neurons in the medial basal hypothalamus |
| Q52301530 | Dynorphin A 1-17 biotransformation in inflamed tissue, serum and trypsin solution analysed by liquid chromatography-tandem mass spectrometry. |
| Q38715846 | Dynorphin A analogs for the treatment of chronic neuropathic pain |
| Q34335745 | Dynorphin A selectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion neurons in cell culture |
| Q43700373 | Dynorphin A(6-12) analogs suppress thermal edema. |
| Q48956676 | Dynorphin and Vasopressin: Common Localization in Magnocellular Neurons |
| Q41335941 | Dynorphin and epilepsy |
| Q89956203 | Dynorphin and its role in alcohol use disorder |
| Q36256365 | Dynorphin converting enzyme with unusual specificity from rat brain |
| Q48882251 | Dynorphin immunocytochemistry in the rat central nervous system |
| Q31032837 | Dynorphin induced magnetic ordering in lipid bilayers as studied by (31)P NMR spectroscopy |
| Q48257725 | Dynorphin(1-8) immunoreactivity in brainstem and hypothalamic nuclei of normotensive and age-matched hypertensive rat strains |
| Q48591024 | Dynorphin(1–13) improves survival in cats with focal cerebral ischaemia |
| Q48696589 | Dynorphin-(1–13)-Like Immunoreactivity in Central Nervous System and Pituitary Gland of Spontaneously Hypertensive Rats |
| Q26860519 | Dynorphin--still an extraordinarily potent opioid peptide |
| Q44352128 | Dynorphin-Related Opioid Peptides in the Neurointermediate Pituitary of Rats Are Not ?-N-Acetylated |
| Q43647312 | Dynorphin-degrading cysteine protease is highly specific for paired arginine residues |
| Q72544934 | Dynorphin-immunoreactive neurons in the central nervous system of the rat |
| Q48898826 | Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptor |
| Q36573427 | Dysfunctions of Regulatory Neurotransmitters and Neuropeptides following Spinal Cord Injury |
| Q44335419 | E-2078, a potent, selective and stable dynorphin analog with preferential activity for the kappa-opioid receptor subtype on the mouse vas deferens neuroeffector junction |
| Q35190847 | Effect of three peptidase inhibitors on antinociceptive potential and toxicity with intracerebroventricular administration of dynorphin A (1-17) or (1-13) in the rat. |
| Q44445822 | Effects of receptor-selective opioids on operant behavior in morphine-treated and untreated rats |
| Q40134061 | Endogenous opiates: 1981 |
| Q40133639 | Endogenous opioid peptides: review of physiological, pharmacological and clinical aspects |
| Q34060986 | Endogenous opioids and reward |
| Q71977743 | Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages |
| Q48836969 | Enkephalin immunoreactivity in synaptoid elements on glial cells in the rat neural lobe |
| Q49030356 | Enkephalin in the rat neural lobe: immunocytochemical evidence for its presence within synaptic elements on pituicytes |
| Q48820662 | Enkephalin-glial interaction and its consequence for vasopressin and oxytocin release from the rat neural lobe. |
| Q49108881 | Enzymatic cleavage prior to antibody incubation as a method for neuropeptide immunocytochemistry |
| Q34247866 | Evidence for a Selective Processing of Proenkephalin B into Different Opioid Peptide Forms in Particular Regions of Rat Brain and Pituitary |
| Q28608943 | G Proteins and Opioid Receptor-Mediated Signalling |
| Q28141916 | Hippocampal cholinergic neurostimulating peptides (HCNP) |
| Q72746087 | Histamine Release Induced by Dynorphin-(1-13) from Rat Mast Cells |
| Q34248436 | Human leumorphin is a potent, kappa opioid receptor agonist |
| Q41293219 | Identification of dynorphins as endogenous ligands for an opioid receptor-like orphan receptor |
| Q36295234 | Immunohistochemical distribution of alpha-neo-endorphin/dynorphin neuronal systems in rat brain: evidence for colocalization |
| Q37604325 | Immunohistochemical distribution of dynorphin B in rat brain: relation to dynorphin A and alpha-neo-endorphin systems |
| Q48872243 | Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway |
| Q33727378 | Increased spinal prodynorphin gene expression in reinflammation-associated hyperalgesia after neonatal inflammatory insult |
| Q44352405 | Involvement of dynorphin and the kappa opioid receptor in feeding |
| Q36311323 | Isolation and amino acid sequence analysis of a 4,000-dalton dynorphin from porcine pituitary |
| Q28265680 | Isolation and structural organization of the human preproenkephalin B gene |
| Q44352107 | Isolation and structure of dynorphin, an opioid peptide, from porcine duodenum |
| Q24311708 | Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor |
| Q71246374 | Isolation of a brain peptide identical to the intestinal PHI (peptide HI) |
| Q44330265 | LEU5enkephalin containing peptides derived from a common precursor: Evaluation of opioid activity in in vitro bioassays |
| Q28344555 | Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys |
| Q67676155 | Localization of chemical messengers in magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: An immunohistochemical study using experimental manipulations |
| Q24614482 | Metorphamide: isolation, structure, and biologic activity of an amidated opioid octapeptide from bovine brain |
| Q30618753 | Molecular dynamics simulations predict a tilted orientation for the helical region of dynorphin A(1-17) in dimyristoylphosphatidylcholine bilayers |
| Q34056649 | Neuropeptide Y: complete amino acid sequence of the brain peptide |
| Q40096848 | New directions in the understanding and management of pain |
| Q34264951 | Novel C-terminally amidated opioid peptide in human phaeochromocytoma tumour |
| Q41570091 | Opiate analgesia and its antagonism in dental event-related potentials: evidence for placebo antagonism |
| Q48895431 | Opiate receptor binding sites in human brain |
| Q44353302 | Opiate receptors and opioid peptides: an overview |
| Q43070545 | Opiate tolerance and dependence: receptors, G-proteins, and antiopiates |
| Q90479657 | Opioid Receptors in Immune and Glial Cells-Implications for Pain Control |
| Q44352676 | Opioid actions on mammalian spinal neurons |
| Q40090875 | Opioid modulation of appetite |
| Q72570822 | Opioid peptides |
| Q44352136 | Opioid peptides have found their roots |
| Q34729984 | Opioid receptor desensitization: mechanisms and its link to tolerance |
| Q35232070 | Opioid receptors and their pharmacological profiles |
| Q67737183 | Pain and Tooth Pulp Evoked Potentials |
| Q40096837 | Pain, nociception and spinal opioid receptors |
| Q47988479 | Parallel stimulations of in vitro and in situ [35S]GTPgammaS binding by endomorphin 1 and DAMGO in mouse brains |
| Q33442900 | Peptide kappa opioid receptor ligands: potential for drug development |
| Q39478053 | Peptide neuroregulators: the opioid system as a model |
| Q49015765 | Peptides and transmitter enzymes in hypothalamic magnocellular neurons after administration of hyperosmotic stimuli: comparison between messenger RNA and peptide/protein levels |
| Q44343729 | Peripheral selectivity and apparent efficacy of dynorphins: comparison to non-peptidic kappa-opioid agonists in rhesus monkeys |
| Q44349579 | Pharmacokinetics of intravenous dynorphin A(1-13) in opioid-naive and opioid-treated human volunteers. |
| Q41889433 | Pharmacological characterization of the inhibitory effects of neurotensin on the rabbit ileum myenteric plexus preparation |
| Q48642391 | Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations |
| Q48898838 | Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regions |
| Q37603499 | Pro-dynorphin peptides are found in the same neurons throughout rat brain: immunocytochemical study |
| Q44330217 | Regional interactions of opioid peptides at μ and δ sites in rat brain |
| Q37691150 | Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus |
| Q36318086 | Rimorphin, a unique, naturally occurring [Leu]enkephalin-containing peptide found in association with dynorphin and alpha-neo-endorphin |
| Q36282529 | Search of the human proteome for endomorphin-1 and endomorphin-2 precursor proteins. |
| Q44342839 | Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide |
| Q46860827 | Separate origins for the dynorphin and enkephalin immunoreactive fibers in the inferior mesenteric ganglion of the guinea pig |
| Q37692494 | Sequence and expression of the rat prodynorphin gene |
| Q48749067 | Simultaneous determination of leu-enkephalin localization and [3H] gamma-aminobutyric acid uptake in rat striatal cell cultures |
| Q48846694 | Simultaneous differentiation of three opiate receptor subpopulations by computer modelling |
| Q45850638 | Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies |
| Q44890607 | Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis |
| Q44387092 | Structural studies of [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bond |
| Q34136307 | Structure and regulation of opioid receptors |
| Q43070634 | Structure-activity relationship studies of dynorphin A and related peptides |
| Q44415335 | Structure–activity relationships of dynorphin analogs substituted in positions 2 and 3 |
| Q44352506 | Subcellular Distribution of Opioid Peptides in Rat Hypothalamus and Pituitary |
| Q34527850 | Subcellular Localization, Partial Purification, and Characterization of a Dynorphin Processing Endopeptidase from Bovine Pituitary |
| Q41907390 | Subunit structure and purification of opioid receptors |
| Q46474174 | Synthesis and properties of β-endorphin analogs containing the dynorphin-(1-13) sequence |
| Q36992406 | The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective |
| Q43074317 | The Hypothalamic Control of the Menstrual Cycle and the Role of Endogenous Opioid Peptides |
| Q37946259 | The dynorphin/κ-opioid receptor system and its role in psychiatric disorders |
| Q44352239 | The effects of stress on central nervous system concentrations of the opioid peptide, dynorphin |
| Q41525051 | The hemorphins: A new class of opioid peptides derived from the blood protein hemoglobin |
| Q41940141 | The role of neuropeptides in suicidal behavior: a systematic review |
| Q54479222 | The role of the endogenous opiates in zinc deficiency anorexia |
| Q42133929 | The stimulation of glycogenolysis in isolated hepatocytes by opioid peptides |
| Q44330436 | Tissue distribution of messenger RNAs coding for opioid peptide precursors and related RNA |
| Q44352155 | Yet another opioid peptide? |
| Q41775466 | kappa-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat. |
| Q37455456 | kappa-Opioid receptor signaling and brain reward function |
| Q42246790 | ‘Dystonia’-like postural asymmetry after microinjection of ACTH N-terminal fragments but not after ACTH1−39 in rat brainstem suggests role of neuropeptide mutation in genetic movement disorder |
Search more.